Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy.
Ontology highlight
ABSTRACT: The present study aims to develop a delivery system that can carry small interference RNA (siRNA) with small-molecule chemotherapeutic drugs, which can be used in cancer treatment. The drug delivery system combines the advantages of a therapeutic agent with two different mechanisms to ensure that it is used efficiently for cancer therapy. In this study, a nanostructured lipid carrier system was prepared, Docetaxel was loaded to these systems, and the Eph siRNA was adsorbed to the outer surface. In addition, DOTAP was added to the lipophilic phase to load a positive charge on the lipidic structure for interaction with the cells. Moreover, characterization, cytotoxicity, and transfection procedures were performed on the whole system. This candidate system was also compared to Taxotere, which
SUBMITTER: Senel B
PROVIDER: S-EPMC10938417 | biostudies-literature | 2024 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA